Pharmaceutical industry: Jean-François Brochard new head of Leem

AI justification

Pharmaceutical industry leadership risks prioritizing profit over equitable healthcare access. | The election of Jean-François Brochard as president of the Leem represents institutional continuity but raises concerns about the pharmaceutical industry's influence on healthcare policy. While the association may advocate for innovation and investment, the focus on profit-driven priorities in a context of public finance constraints risks exacerbating inequalities in access to essential medicines and